Summary
The acute effects of glucagon (mol. wt. 3500) and its interactions with insulin were studied in the forearm during eight studies in seven normal, post-absorptive males. The protocol consisted of a 2 h baseline, 1 h glucagon perfusion (mean glucagon increment, 691±50 pg/ml), 1 h perfusion of both insulin and glucagon (mean insulin increment of 105 ±13 mU/l) and a 30 min recovery period. Simultaneous arterial (A), deep venous (DV), and superficial venous (SV) blood samples were obtained at 30 min intervals. Perfusion of glucagon resulted in a decrease in (A-DV) non-esterified fatty acids of-0.128±0.057 mmol/l (n=7, p<0.05) and (A-SV) non-esterified fatty acids of -0.081±0.036 mmol/l (n=7, p<0.05), as well as a change in deep compartment uptake of glycerol after 60 min of -0.044±0.019 μmol/min/100 ml of forearm tissue (n=6, p<0.05), indicating increased lipolysis. There was also a decrease in net glucose uptake as reflected by a change in (A-DV) of -0.24±0.09 mmol/l (n=7, p<0.025) and (A-SV) of 0.10± 0.05 mmol/l (n=7, p<0.05). There was also a net decrease in deep arteriovenous differences of potassium in six of seven subjects. Insulin levels, similar to those found after a meal, rapidly reversed the effects of glucagon on non-esterified fatty acid, glucose and potassium. These effects persisted throughout the recovery period.
Article PDF
Similar content being viewed by others
References
Sherwin RS, Bastl C, Finkelstein FO, Fisher M, Black H, Hendler R, Felig P (1976) Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. J Clin Invest 57: 722–731
Sherwin RS, Joshi P, Hendler R, Felig P, Conn HO (1974) Hyperglucagonemia in Laennec's cirrhosis. N Engl J Med 290: 239–242
Meguid MM, Brennan MF, Aoki TT, Muller WA, Ball MR, Moore FD (1974) Hormones — substrate interrelationships following trauma. Arch Surg 109: 776–783
Rocha DM, Santeusanio F, Faloona GR, Unger RH (1973) Abnormal pancreatic alpha cell function in bacterial infection. N Engl J Med 228: 700–703
Johnston DI, Bloom SR, O'Brian D (1975) Pancreatic glucagon in diabetic ketoacidosis. Arch Dis Child 50: 329
Muller WA, Faloona GR, Unger RH (1973) Hyperglucagonemia in diabetic ketoacidosis Am J Med 54: 52–57
Kuku SF, Jaspan JB, Emmanouel DS, Zeidler A, Katz AI, Rubenstein AH (1976) Heterogeneity of plasma glucagon: Circulating components in normal subjects and patients with chronic renal failure. J Clin Invest 58: 742–750
Williams RH (1974) In: Williams RH (ed) Williams' textbook of endocrinology, 5th ed. Saunders, Philadelphia p 547–550
Lefebvre PJ, Luyckx A (1968) Lipolytic action of glucagon in vitro and in vivo. Exerpta Medica Monograph: Pathophysiology of adipose tissue, p 257–267
Lefebvre PJ (1972) Glucagon and lipid metabolism. In: Lefebvre PJ, Unger RH (eds) Glucagon: Molecular physiology, clinical and therapeutic implications. Pergamon Press, Oxford New York, p 109–121
Lefebvre PJ (1975) Glucagon and adipose tissue. Biochem Pharmacol 24: 1261–1266
Sarcione EJ, Back N, Sokal JE, Mehlman B, Knoblock E (1963) Elevation of plasma epinephrine levels produced by glucagon in vivo. Endocrinology 72: 523–526
Gerich JE, Lorenzi M, Bier D, Schneider V, Tsalikian E, Karam JH, Forsham PH (1975) Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. N Engl J Med 292: 985–990
Lefebvre, PJ, Luyckx AS (1979) Glucagon and diabetes: A reappraisal. Diabetologia 15: 347–354
Fineberg SE, Merimee TJ (1973) Effects of comparative perfusions of equimolar, single component insulin and proinsulin in the human forearm. Diabetes 22: 676–685
Andres R, Zierler KL, Anderson H, Stainsby W, Cader G, Ghrayyib A, Lilienthal J (1954) Measurements of blood flow and volume in the forearm of man with notes on the theory of indicator dilution and on the production of turbulence, hemolysis, and vasodilitation by intravascular injection. J Clin Invest 33: 482–504
Wahren J (1966) Quantitative aspects of blood flow and oxygen uptake in the human forearm during rhythmic exercise. Acta Physiol Scand [Suppl] 67: 269
Bergmeyer J (ed) (1974) Methods of enzymatic analysis. Academic Press, New York
Novak M (1965) Colorimetric ultramicro method for the determination of free fatty acids. J Lipid Res 6: 431–433
Baltzan MA, Andres R, Cader G, Zierler KL (1962) Heterogeneity of forearm metabolism with special reference to free fatty acids. J Clin Invest 41: 116–125
Dixon W, Massey F Jr (1969) Introduction to statistical analysis. McGraw-Hill Book Co, New York
Marliss EB, Aoki TT, Unger RH, Soeldner JS, Cahill GF (1970) Glucagon levels and metabolic effects in fasting man. J Clin Invest 49: 2256–2262
Schade DS, Eaton RP (1975) Modulation of fatty acid metabolism by glucagon in man. Diabetes 24: 502–515
Liljenquist JE, Bomboy JD, Lewis SB, Sinclair-Smith BL, Felts PW, Lacy WW, Crofford OB, Liddle G (1974) Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J Clin Invest 53: 190–197
Schade DS, Eaton RP (1975) The contribution of endogenous insulin secretion to ketogenic responses to glucagon in man. Diabetologia 11: 555–562
Froesch RE, Burgi H, Bally P, Labhart A (1965) Insulin inhibition of spontaneous adipose tissue lipolysis and effects of fructose and glucose metabolism. Mol Pharmacol 1: 280–296
Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH (1976) Effects of physiologic levels of glucagon and human growth hormone on human carbohydrate and lipid metabolism. J Clin Invest 57: 875–884
Ludabaek K, Christensen SE, Hansen AP, Iversen J, Orskov H, Seyer-Hansen K, Alberti KGMM, Whitefoot R (1976) Failure of somatostatin to correct manifest diabetic ketoacidosis. Lancet II: 215–218
Raskin P, Unger RH (1978) Hyperglucagonemia and its suppression: Importance in the metabolic control of diabetes. N Engl J Med 299: 1366–1367
Dagenais GR, Tancredi RG, Zierler KL (1976) FFA oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in human forearm. J Clin Invest 58: 421–431
Heaf DJ, Kaijser L, Eklund B, Carson LA (1977) Differences in heparin-released lipolytic activity in the superficial and deep veins of the human forearm. Eur J Clin Invest 7: 195–199
Aoki TT, Muller WA, Brennan, MF, Cahill GF (1974) Effect of glucagon on amino acid and nitrogen metabolism in fasting man. Metabolism 23: 805–814
Pozefsky T, Tancredi R, Moxley R, Dupre J, Tobin J (1976) Metabolism of forearm tissues in man. Studies with glucagon. Diabetes 25: 128–136
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose-fatty acid cycle: Its roles in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet I: 785–789
Schonfeld G, Kipnis D (1968) Effect of free fatty acids on carbohydrate and fatty acid metabolism in rat diaphragm. Am J Physiol 215: 513–522
Lindsey AL, Madison LL (1972) Is glucagon a gluconeogenic hormone in vivo? Diabetes 21 [Suppl 1]: 331
Wolfson SK, Ellis S (1956) Effects of glucagon on plasma potassium. Proc Soc Exp Biol Med 91: 226–228
Galansino G, D'Amico G, Kanameishi D, Berlinger F, Foa P (1960) Hyperglycemic substances originating in the pancreatoduodenal area. Am J Physiol 198: 1059–1062
Pullman T, Lavender A, Aho I (1967) Direct effects of glucagon on renal hemodynamics and excretion of inorganic ions. Metabolism 16: 358–373
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider, S.H., Fineberg, S.E. & Blackburn, G.L. The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue. Diabetologia 20, 616–624 (1981). https://doi.org/10.1007/BF00257430
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00257430